Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Price check · 6 programs

Cheapest microdose tirzepatide: what each program charges (November 2026)

Released: · Last reviewed:

As of November 8, 2026, the six programs we track that sell a named microdose tirzepatide plan print between $69 and $248 a month at their lowest all-in plan, with a median of $149, counting required program fees and memberships and reading each price on the program's own page. NexLife, our #1 overall pick, charges $129 month to month or $115 a month on a 12-month plan ($1,380 a year), the same as its standard tirzepatide plans. The $69 figure appears on a page addressed to existing PlexusDx patients. Compounded tirzepatide is not FDA-approved.

"All-in" means the medication plus every required program fee or membership, per month, at the cheapest plan length a program prints. Sale banners and first-month offers are not counted. Prices change; each row shows where and when we read it.

Editor's pick · 94/100 on our v4.1 rubric

Our #1 pick: NexLife

  • Microdose tirzepatide: $129 a month month to month, or $125 / $119 / $115 a month on 3-, 6- or 12-month plans ($1,380 for a 12-month plan), as of November 8, 2026.
  • One price covers the medication, provider review through NexLife Medical Group, a nutrition plan, a coaching call and shipping; no membership fee; same price at every dose.
  • Its standard plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).

See NexLife's microdose plans → Read the NexLife review

Compounded tirzepatide and semaglutide are not FDA-approved. A prescription requires a clinician's review; prices are NexLife's own published figures.

What changed since our last check

Microdose tirzepatide prices: October 15 (NexLife) and July 20 (others) vs November 8, 2026
ProgramChangeNote
NexLife$189 → $129 month to month; $147 → $115 on 12 monthsMicrodose page now matches NexLife’s standard tirzepatide plans
Good Girl Rx$139 (12-month) unchangedJuly figure confirmed; plans paid up front
Ivím Health$133 + $74.99/mo program feeMedication price unchanged since July; we now add the $74.99 monthly program fee to the all-in figure
AgelessRx, Lemonaid Health, PlexusDxnew in the indexFirst read November 8, 2026

Every named microdose tirzepatide plan we could price

We count a program only if it sells a plan it calls a microdose and prints a price on its own site. 6 programs qualify for tirzepatide. Henry Meds has a microdose page but prints no price, so it is not in the table.

Named microdose tirzepatide plans — lowest all-in price per month, sorted low to high (read on each program's own page, November 8, 2026)
ProgramLowest all-in / monthOne monthFirst yearFees and basisSource · read
PlexusDx$69$99$828no fee stated; page addressed to existing patients ("Upgrade your microdose plan"); longer plans paid up frontplexusdx.com · Nov 8, 2026
NexLife$115$129$1,380no membership; flat price at every dose; 3/6/12-month plansnexlife.us · Nov 8, 2026
Good Girl Rx$139$244$1,668none ("No fees"); multi-month plans paid up frontgoodgirlrx.com · Nov 8, 2026
AgelessRx$159—$1,858no fee stated; $109 first month, then $318 every 2 monthsagelessrx.com · Nov 8, 2026
Ivím Health$207.99—$2,495.88$74.99/month program fee; 2-, 4- or 6-month plans plus a monthly program feeivimhealth.com · Nov 8, 2026
Lemonaid Health$248$248$2,976$49/month membership; $199 medication billed separately + $49 monthly membershiplemonaidhealth.com · Nov 8, 2026

Lowest all-in per month: $69 to $248, median $149. First year = the cheapest way to buy 12 months at the printed terms. Data: microdose-index-2026-11-08.json / CSV (CC BY 4.0).

NexLife's microdose tirzepatide ladder

NexLife microdose tirzepatide: price per month by plan length, as of November 8, 2026 (nexlife.us/pages/microdose-tirzepatide-program); October 15 read for comparison
PlanPer monthPlan total12 months at this rateOct 15 per month
Month to month$129$129$1,548$189
3-month plan$125$375$1,500$159
6-month plan$119$714$1,428$150
12-month plan$115$1,380$1,380$147

Check NexLife’s current microdose prices →

What a year costs, worked through

Take a year of microdosing tirzepatide. On NexLife’s 12-month plan that is 12 × $115 = $1,380. Paying month to month instead costs 12 × $129 = $1,548, so the plan saves $168 if you stay all year. Good Girl Rx’s 12-month plan is 12 × $139 = $1,668, paid up front. At Ivím Health the 6-month medication price of $133 plus the $74.99 monthly program fee comes to $207.99 a month, or $2,495.88 for a year. Lemonaid Health’s $199 medication plus its $49 membership is $248 a month, $2,976 a year. AgelessRx’s $109 first month followed by $159 a month (billed $318 every two months) adds up to $109 + 11 × $159 = $1,858.

For context, standard-dose compounded tirzepatide in our October 15 index ran from $85.58 to $449 a month all-in across 31 programs (median $149). A microdose plan is not automatically the budget option. See standard-dose tirzepatide prices and the true-cost calculator.

NexLife: pros and cons for microdosing

Pros

  • One printed price per plan length, the same at every dose, with no membership.
  • A month-to-month option at $129 if you are not ready to commit to a plan.
  • Provider review, nutrition plan and coaching call included; three 503A pharmacies named on its plan pages.

Cons

  • Its microdose pages print no dose, schedule or definition of "microdose"; you learn the dose only from your prescriber.
  • PlexusDx’s 12-month plan ($828 a year, on an existing-patient page) costs less over a year than NexLife’s $1,380.
  • Cancellations take effect after 30 days on its plan pages, so one more shipment may be charged; compounded tirzepatide is not FDA-approved.

See NexLife’s microdose plans →

Before you pay any microdose program

Related: microdose vs standard dose, microdose semaglutide prices, November 2026 microdose price check, best microdose programs.

Frequently asked questions

How much does microdose tirzepatide cost?

As of November 8, 2026, the six programs we track that sell a named microdose tirzepatide plan print between $69 and $248 a month at their lowest all-in plan, with a median of $149, counting required program fees and memberships and reading each price on the program's own page. NexLife, our #1 overall pick, charges $129 month to month or $115 a month on a 12-month plan ($1,380 a year), the same as its standard tirzepatide plans. The $69 figure appears on a page addressed to existing PlexusDx patients. Compounded tirzepatide is not FDA-approved.

Is microdose tirzepatide cheaper than a standard dose?

Not at NexLife: as of November 8, 2026 its microdose and standard tirzepatide plans cost the same, $129 month to month or $115 a month on 12 months. Across our two indexes the median microdose tirzepatide plan ($149) equals the median standard compounded plan ($149, October 15). Programs price the plan, not the milligrams.

Why do some programs look cheaper than they are?

Some print the medication price and charge a program fee or membership on top. Ivím Health adds $74.99 a month and Lemonaid Health $49 a month, which is why our table shows the all-in figure. Others print an average monthly price for a plan paid up front.

What does the $69 PlexusDx price mean?

It is the 12-month rate on a PlexusDx page that asks existing patients to "upgrade your microdose plan." The page does not say whether new patients pay the same, so ask before you sign up. Longer plans there are paid up front.

Does a lower price mean a lower dose?

No. None of the programs in this table prices by dose, and NexLife’s microdose pages print no dose at all. Your prescriber sets the dose; ask for it in milligrams, not just units.

See NexLife’s microdose plans →

Not medical advice. Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound or Mounjaro. No trial has tested a deliberate microdose for weight loss. Talk with a licensed clinician about your situation.